->

I-Tag: i-follicular lymphoma

Ikhaya / Unyaka Omisiwe

, , , , , ,

I-Tisagenlecleucel igunyazwe yi-FDA nge-lymphoma ebuyele emuva noma e-refractory follicular

Juni 2022: Ngemva kwemigqa emibili noma ngaphezulu yokwelashwa kwe-systemic, i-FDA yaklomelisa i-tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) yagunyaza ngokushesha iziguli ezikhulile ezine-lymphoma ebuyelelwe emuva noma e-refractory follicular (FL).T..

, , , , , , ,

I-FDA inikeze imvume yokusheshisa ye-axicabtagene ciloleucel ye-folloma lymphoma ebuyile noma ephikisayo.

Agasti 2021: I-FDA inikeze i-axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) imvume esheshayo ezigulini ezikhulile ezine-lymphoma ephindaphindekayo noma e-refractory follicular lymphoma (FL) ngemva kwemigqa emibili noma ngaphezulu yokwelashwa kwe-systemic. Ingoma..

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton